The problem, as ever, is that the study was designed to fail. In a piece published by The Brownstone Institute, Dr. Pierre Kory highlights the study’s flaws:
"Ivermectin is the Biggest Threat to the Vaccine Industry, "Dr. Paul Marik tells Emerald Robinson. Doctors need to speak out about what is happening in the world and why they are legitimately afraid to do so.
This webinar takes a detailed dive into the statistics and the communication strategy of the TOGETHER trial. Alexandros Marinos, a self-described “aspiring practical philosopher,” talked about the dozens of statistical anomalies he uncovered in the study, while journalist and filmmaker Phil Harper discussed the communications strategy deployed to make headlines even before the results were published.
In this week’s FLCCC Weekly Update Dr. Pierre Kory and Dr. Flavio Cadegiani walk the audience through the TOGETHER trial, which was recently released and made headlines around the world regarding the effectiveness of ivermectin.
Trials of generic medicines that are funded and influenced by profit-driven pharmaceutical companies will always fail.
Treating early is imperative. Yet the TOGETHER trial studied patients where they started treatment up to eight days after the onset of symptoms.